Merck in Brazil
Prodome Limitada, a joint venture between Merck and Brazilian drug firm Ache Group, will manufacture and market Merck human health products in Brazil, and export finished products and bulk ingredients to other markets. Ache, the largest domestic pharmaceutical business, has a majority position in the joint venture.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.